Economic Evaluations of Pharmacologic Treatment for Opioid Use Disorder: A Systematic Literature Review.

ABSTRACT:

Objective

The crisis of opioid use puts a strain on resources in the United States and worldwide. There are 3 US Food and Drug Administration-approved medications for treatment of opioid use disorder: methadone, buprenorphine, and injectable extended-release naltrexone (XR-NTX). The comparative effectiveness and cost vary considerably among these 3 medications. Economic evaluations provide evidence that help stakeholders efficiently allocate scarce resources. Our objective was to summarize recent health economic evidence of pharmacologic treatment of opioid use disorder interventions.

Methods

We searched PubMed for peer-reviewed studies in English from August 2015 through December 2019 as an update to a 2015 review. We used the Drummond checklist to evaluate and categorize e

SUBMITTER: Onuoha EN 

PROVIDER: S-EPMC8591614 | biostudies-literature | 2021 Jul

REPOSITORIES: biostudies-literature